Requirement for producer cell line for GMP viral vector packaging

Award

Buyers

Value

£111,000

Suppliers

Classifications

  • Disposable non-chemical medical consumables and haematological consumables

Tags

  • award

Submission Deadline

5 years ago

Published

3 years ago

Description

NHSBT's Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

  • Contract Agreement

    The official contract terms, conditions, and scopes of work.

    Download

  • Award Notice

    Details on the tender award and selected suppliers.

    Download

Similar Contracts

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

NHS Blood and Transplant (NHSBT)

Marnie Watkins

[email protected]

+44 1179217241

Timeline complete

Publish
Bid
Evaluate
Award
Complete